DISPOSAL OF HUMAN CHYLOMICRONS ADMINISTERED INTRAVENOUSLY IN ISCHEMIC HEART DISEASE AND ESSENTIAL HYPERLIPEMIA

被引：26
|
作者：
NESTEL, PJ
DENBOROUGH, MA
ODEA, J
机构：
来源：
CIRCULATION RESEARCH | 1962年 / 10卷 / 05期
关键词：
D O I：
10.1161/01.RES.10.5.786
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：786 / &
相关论文
共 50 条
  • [31] CIRCULATORY INDEXES DURING EXERCISE IN PATIENTS WITH ISCHEMIC HEART DISEASE EFFECT OF DILAZEP ADMINISTERED FOR LONG PERIODS
    AJISAKA, R
    MIYAHARA, Y
    NIWA, A
    IIIZUMI, T
    FUJIWARA, H
    TANIGUCHI, K
    TAKEUCHI, J
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1979, 43 (08): : 809 - 809
  • [32] HYPERLIPEMIA AMONG 1407 DANISH CHILDREN WHOSE FATHERS HAVE DIED FROM ISCHEMIC-HEART-DISEASE BEFORE AGE 45
    ANDERSEN, GE
    HEJL, M
    CHRISTENSEN, NC
    BOTT, H
    LOUS, P
    FRIISHANSEN, B
    ACTA PAEDIATRICA SCANDINAVICA, 1981, 70 (06): : 843 - 849
  • [33] HIGH PREVALENCE OF ISCHEMIC-HEART-DISEASE AND HYPERLIPEMIA IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH MICROALBUMINURIA
    MATTOCK, MB
    SCOTT, GS
    ELGOHARI, R
    JACKSON, PG
    KEEN, H
    DIABETOLOGIA, 1986, 29 (08) : A570 - A570
  • [34] Changes in human atrial connexin expression in atrial fibrillation and ischemic heart disease
    Patel, P
    Jones, DG
    Hadjinikolaou, L
    Glenville, B
    Stanbridge, RD
    Severs, NJ
    Peters, NS
    CIRCULATION, 1997, 96 (08) : 92 - 92
  • [35] Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus
    Shi, Meilynn
    Feinstein, Matthew J.
    HEART FAILURE CLINICS, 2025, 21 (02) : 227 - 239
  • [36] Platelet Aggregation and Endothelial Function in Patients with Complicated Essential Hypertension (Ischemic Stroke) and Coronary Heart Disease
    Shimohina, N. Yu.
    Petrova, M. M.
    Savchenko, A. A.
    Smertina, E. G.
    Ionova, V. G.
    Tanashyan, M. M.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2010, 149 (01) : 18 - 20
  • [37] ''Essential'' phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease
    Klimov, AN
    Konstantinov, VO
    Lipovetsky, BM
    Kuznetsov, AS
    Lozovsky, VT
    Trufanov, VF
    Plavinsky, SL
    Gundermann, KJ
    Schumacher, R
    CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (06) : 779 - 784
  • [38] Platelet Aggregation and Endothelial Function in Patients with Complicated Essential Hypertension (Ischemic Stroke) and Coronary Heart Disease
    N. Yu. Shimohina
    M. M. Petrova
    A. A. Savchenko
    E. G. Smertina
    V. G. Ionova
    M. M. Tanashyan
    Bulletin of Experimental Biology and Medicine, 2010, 149 : 18 - 20
  • [39] Modeling ischemic heart disease: only matured human iPS-derived cardiomyocytes are sensitive to ischemic injury
    Peters, M. C.
    Van Adrichem, I.
    Doevendans, P. A. M.
    Chamuleau, S. A. J.
    Neef, K.
    Sluijter, J. P. G.
    EUROPEAN HEART JOURNAL, 2021, 42 : 3251 - 3251
  • [40] Impact of estimated glucose disposal rate for identifying prevalent ischemic heart disease: findings from a cross-sectional study
    Jin Xuan
    Du Juan
    Niu Yuyu
    Ji Anjing
    BMC Cardiovascular Disorders, 22
12345